Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Journal
Document Type
Year range
1.
FEBS J ; 288(17): 5148-5162, 2021 09.
Article in English | MEDLINE | ID: covidwho-1189682

ABSTRACT

Small linear motifs targeting protein interacting domains called PSD-95/Dlg/ZO-1 (PDZ) have been identified at the C terminus of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins E, 3a, and N. Using a high-throughput approach of affinity-profiling against the full human PDZome, we identified sixteen human PDZ binders of SARS-CoV-2 proteins E, 3A, and N showing significant interactions with dissociation constants values ranging from 3 to 82 µm. Six of them (TJP1, PTPN13, HTRA1, PARD3, MLLT4, LNX2) are also recognized by SARS-CoV while three (NHERF1, MAST2, RADIL) are specific to SARS-CoV-2 E protein. Most of these SARS-CoV-2 protein partners are involved in cellular junctions/polarity and could be also linked to evasion mechanisms of the immune responses during viral infection. Among the binders of the SARS-CoV-2 proteins E, 3a, or N, seven significantly affect viral replication under knock down gene expression in infected cells. This PDZ profiling identifying human proteins potentially targeted by SARS-CoV-2 can help to understand the multifactorial severity of COVID19 and to conceive effective anti-coronaviral agents for therapeutic purposes.


Subject(s)
COVID-19/genetics , Host-Pathogen Interactions/genetics , PDZ Domains/genetics , SARS-CoV-2/genetics , COVID-19/virology , Carrier Proteins/genetics , Coronavirus Nucleocapsid Proteins/genetics , Humans , Kinesins/genetics , Myosins/genetics , Protein Binding/genetics , Protein Interaction Domains and Motifs/genetics , Protein Tyrosine Phosphatase, Non-Receptor Type 13/genetics , SARS-CoV-2/pathogenicity , Viral Envelope Proteins/genetics , Viroporin Proteins/genetics , Virus Internalization , Virus Replication/genetics , Zonula Occludens-1 Protein/genetics
SELECTION OF CITATIONS
SEARCH DETAIL